May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Therapeutic Vitrectomy in Uveitis – A Literature Analysis
Author Affiliations & Notes
  • M.D. Becker
    Interdisciplinary Uveitis Center, University of Heidelberg, Heidelberg, Germany
  • N. Harsch
    Interdisciplinary Uveitis Center, University of Heidelberg, Heidelberg, Germany
  • M. Zierhut
    Ophthalmology, University of Tuebingen, Tuebingen, Germany
  • F. Holz
    Ophthalmology, University of Bonn, Bonn, Germany
  • J.L. Davis
    Ophthalmology, Bascom Palmer, Miami, FL
  • Footnotes
    Commercial Relationships  M.D. Becker, None; N. Harsch, None; M. Zierhut, None; F. Holz, None; J.L. Davis, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4079. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.D. Becker, N. Harsch, M. Zierhut, F. Holz, J.L. Davis; Therapeutic Vitrectomy in Uveitis – A Literature Analysis . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4079.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: With the advent of modern vitreoretinal surgical techniques the spectrum for surgical intervention in various forms of uveitis has been notably expanded. Removal of optically relevant vitreous opacities, improvement of secondary macular edema, delamination of epiretinal membranes and release of traction in presence of abnormal vitreoretinal adhesions represent indications for vitreoretinal procedures in uveitis patients. Methods: A total of 60 publications from 1979 to 2004 about therapeutic vitrectomy were included into the analysis. 1728 patients had been included into all studies and 1934 eyes had been vitrectomized. All publications were analysed and compared concerning anatomical localization, functional results, influence on the activity of intraocular inflammation, preoperative risc factors, influence on macular edema, type of immunosuppression, number of combined procedures, postoperative complications as well as quality of life. Results: Subgroup analysis was performed to show trends although differences in study design made it difficult to compare results directly. The value of vitrectomy to treat chronic cystoid macular edema is still debated. There is only little data on the significance of adequate immunosuppression perioperatively. Conclusions: So far no prospective, controlled clinical trials have been performed to precisely evaluate the role of pars plana vitrectomy as a single or combined surgical procedure in patients with intraocular inflammation. Inconsistent data exist regarding prognostic determinants and the role of perioperative immunosuppression. Here the current knowledge on the subject is reviewed, critically discussed and recommendations for patient management are given. Further studies are needed.

Keywords: vitreoretinal surgery • inflammation • uveitis-clinical/animal model 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.